| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |